Shares of EUDA Health Holdings Limited (NASDAQ:EUDA – Get Free Report) passed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $14.87 and traded as high as $15.69. EUDA Health shares last traded at $15.56, with a volume of 21,385 shares.
Analysts Set New Price Targets
Several analysts have commented on EUDA shares. Wall Street Zen upgraded shares of EUDA Health to a “hold” rating in a research note on Saturday, October 17th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of EUDA Health in a report on Tuesday, November 3rd. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $55.00.
Read Our Latest Stock Analysis on EUDA
EUDA Health Stock Performance
The company has a fifty day moving average price of $15.69 and a 200-day moving average price of $14.87. The company has a current ratio of 2.53, a quick ratio of 2.53 and a debt-to-equity ratio of 0.01.
EUDA Health (NASDAQ:EUDA – Get Free Report) last posted its earnings results on Tuesday, September 29th. The company reported ($0.17) EPS for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.57). The firm had revenue of $1.73 million during the quarter, compared to analysts’ expectations of $9.61 million.
About EUDA Health
EUDA Health Limited (NASDAQ: EUDA) is a digital health company focused on improving access to healthcare through technology-enabled services. The company’s activities center on virtual care and healthcare platforms designed to connect patients with providers and support the delivery of convenient, digitally enabled medical services. EUDA Health’s offerings include telehealth and other digital healthcare solutions, with an emphasis on behavioral and mental health services. Its platforms are intended to help patients access care remotely while supporting healthcare professionals with tools for communicating with and managing patients.
Further Reading
- Five stocks we like better than EUDA Health
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for EUDA Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EUDA Health and related companies with MarketBeat.com's FREE daily email newsletter.
